Accelerating Drug Discovery and Development with Primary Human Hepatocytes
Ed LeCluyse, PhD, Chief Scientist of LifeNet Health’s Institute of Regenerative Medicine, presents on the criticality of utilizing primary human hepatocytes in pre-clinical drug development. Topics include:
- How human hepatocytes can fast-forward your target identification
- Application of human hepatocytes in drug metabolism studies and pharmacokinetics
- Fit-for-purpose specifications of various human hepatocyte applications